ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
118.532,68
-1,33%
S&P 500
5.942,47
1,26%
US Dollar vs BRL
6,1822
0,00%
Bitcoin
97.787,75
-0,43%
Brent Oil
76,495
0,00%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Accelerate Diagnostics Inc (AXDX)

  7. Accelerate Diagnostics Inc (AXDX) Notícias

AXDX

Accelerate Diagnostics (AXDX)

Accelerate Diagnostics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AXDX
DataHoraFonteTítuloCódigoCompanhia
05/12/202419:13Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
03/12/202422:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXDXAccelerate Diagnostics Inc
14/11/202417:24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AXDXAccelerate Diagnostics Inc
07/11/202418:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXDXAccelerate Diagnostics Inc
07/11/202418:05PR Newswire (US)Accelerate Diagnostics Reports Third Quarter 2024 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
25/10/202417:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
30/09/202410:15PR Newswire (US)Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ SystemNASDAQ:AXDXAccelerate Diagnostics Inc
08/08/202418:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXDXAccelerate Diagnostics Inc
08/08/202417:05PR Newswire (US)Accelerate Diagnostics Reports Second Quarter 2024 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
08/08/202417:00PR Newswire (US)Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical TrialNASDAQ:AXDXAccelerate Diagnostics Inc
08/08/202412:09PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
23/05/202420:17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
10/05/202418:24Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
08/05/202417:42PR Newswire (US)Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
02/05/202410:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.NASDAQ:AXDXAccelerate Diagnostics Inc
28/03/202417:05PR Newswire (US)Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
07/03/202411:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.NASDAQ:AXDXAccelerate Diagnostics Inc
05/03/202417:59Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AXDXAccelerate Diagnostics Inc
22/01/202423:59Edgar (US Regulatory)Form 424B1 - Prospectus [Rule 424(b)(1)]NASDAQ:AXDXAccelerate Diagnostics Inc
22/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AXDXAccelerate Diagnostics Inc
19/01/202411:20PR Newswire (US)Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private PlacementNASDAQ:AXDXAccelerate Diagnostics Inc
18/01/202409:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
16/01/202409:45PR Newswire (US)Accelerate Diagnostics Announces Launch of Proposed Public OfferingNASDAQ:AXDXAccelerate Diagnostics Inc
07/01/202422:00PR Newswire (US)Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
13/12/202319:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AXDXAccelerate Diagnostics Inc
27/11/202311:15PR Newswire (US)Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®NASDAQ:AXDXAccelerate Diagnostics Inc
09/11/202318:05PR Newswire (US)Accelerate Diagnostics Reports Third Quarter 2023 ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
30/10/202310:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.NASDAQ:AXDXAccelerate Diagnostics Inc
10/08/202317:05PR Newswire (US)Accelerate Diagnostics Reports Second Quarter 2023 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
27/07/202310:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AXDX

Seu Histórico Recente

BOV
PRIO3
PETRORIO ON
BOV
IBOV
Índice Bovespa
BOV
PCAR3
PÃO DE AÇUCAR ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados